Loading...
Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie)
Convalescent plasma therapy was administered in patients with acute, viral respiratory disorders with severe clinical course (SARS- or MERS coronavirus, influenza H1N1, H5N1). These studies suggested that convalescent plasma is likely to improve viral clearance, reduce the length of hospital stay an...
Na minha lista:
| Udgivet i: | Transfusionsmedizin - Immunhämatologie · Hämotherapie · Transplantationsimmunologie · Zelltherapie |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Georg Thieme Verlag KG
2020
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645839/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1090-0408 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|